Abstract
Purpose
To determine the molecular pathology and clinical severity of two pedigrees with a history of early retinal detachment and peripheral retinal vascular abnormalities.
Design
Longitudinal cohort study.
Methods
A longitudinal clinical study and DNA analysis was performed on 49 family members of two pedigrees.
Results
Nine individuals were found to be hemizygous for a mutation at codon 112 (Gly112Glu) of the Norrie disease protein (NDP) in one pedigree. Significant phenotypic heterogeneity was found. The proband presented with a unilateral subtotal retinal detachment at the age of 3 years, and subsequently developed a slowly progressive tractional retinal detachment involving the macula in the contralateral eye at the age of 4 years. One individual had only mild peripheral retinal pigmentary changes with normal vision at the age of 79 years. The remaining seven individuals had varying degrees of peripheral retinal vascular abnormalities and anterior segment findings. Seven affected members of a second pedigree affected by a previously reported mutation, Arg74Cys, also demonstrated wide ocular phenotypic variation.
Conclusion
A novel mutation (Gly112Glu), which represents the most carboxy located, NDP mutation reported, results in significant phenotypic heterogeneity. These data support the contention that the spectrum of ocular disease severity associated with these NDP mutations is broad. Use of terms that characterize this entity by phenotypic appearance, such as familial exudative vitreoretinopathy, do not adequately communicate the potential spectrum of severity of this disorder to affected or carrier family members.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Berger W, Meindl A, van de Pol T, Cremers F, Ropers H, Doerner C et al. Isolation of a candidate gene for Norrie disease by positional cloning. Nat Genet 1992; 1: 199–203.
Chen Z-Y, Hendriks R, Jobling M, Powell J, Breakefield X, Sims K et al. Isolation and characterization of a candidate gene for Norrie disease. Nat Genet 1992; 1: 204–208.
Meindl A, Berger W, Meitinger T, van de Pol D, Achatz H, Dorner C et al. Norrie disease is caused by mutation in an extracellular protein resembling C-terminal globular domain of mucins. Nat Genet 1992; 2: 139–143.
Meitinger T, Meindl A, Bork P, Rost B, Sander C, Haasemann M et al. Molecular modeling of the Norrie disease protein predicts a cystine knot growth factor tertiary structure. Nat Genet 1993; 5: 376–380.
Xu Q, Wang Y, Dabdoub A, Smallwood PM, Williams J, Woods C et al. Vascular development in the retina and inner ear: control by norrin and frizzled-4, a high-affinity ligand-receptor pair. Cell 2004; 116: 883–895.
Ohlmann AV, Adamek E, Ohlmann A, Lutjen-Driscoll E . Norrie gene product is necessary for regression of hyaloid vessels. Invest Ophthalmol Vis Sci 2004; 45: 2384–2390.
Warburg M . Norrie's disease: a new hereditary bilateral pseudotumor of the retina. Acta Ophthal (Copenhagen) 1961; 39: 757–772.
Norrie G . Causes of blindness in children: twenty-five years' experience of Danish Instututes for the Blind. Acta Ophthal (Copenhagen) 1927; 5: 357–386.
Chen Z-Y, Battinelli E, Fielder A, Bundey S, Sims K, Breakefield X et al. A mutation in the Norrie disease gene (NDP) associated with X-linked familial exudative vitreoretinopathy. Nat Genet 1993; 5: 180–183.
Criswick V, Schepens C . Familial exudative vitreoretinopathy. Am J Ophthal 1969; 68: 578–594.
Laqua H . Familial exudative vitreoretinopathy. Albrecht Graefes Arch Klin Exp Ophthalmol 1980; 213: 121–133.
Jacklin H . Falciform fold, retinal detachment, and Norrie's disease. Am J Ophthalmol 1980; 90: 76–80.
Plager D, Orgel I, Ellis F, Hartzer M, Trese M, Shastry B . X-linked recessive familial exudative vitreoretinopathy. Am J Ophthalmol 1992; 114: 145–148.
Toomes C, Downey LM, Bottomley HM, Scott S, Woodruff G, Trembath RC et al. Identification of a fourth locus (EVR4) for familial exudative vitreoretinopathy (FEVR). Mol Vis 2004; 10: 37–42.
Downey LM, Keen T, Roberts E, Mansfield D, Basmashmus M, Inglehearn CF . A new locus for autosomal dominant familial exudative vitreoretinopathy maps to chromosome 11p12–13. Am J Hum Genet 2001; 68: 778–781.
Toomes C, Bottomley HM, Scott S, Mackey DA, Craig JE, Appukuttan B et al. Spectrum and frequency of FZD4 mutations in familial exudative vitreoretinopathy. Invest Ophthalmol Vis Sci 2004; 45: 2083–2090.
Kondo H, Hayashi H, Oshima K, Tahira T, Hayashi K . Frizzled 4 gene (FZD4) mutations in patients with familial exudative vitreoretinopathy. Br J Ophthalmol 2003; 87: 1291–1295.
Robitaille J, MacDonald MLE, Kaykas A, Sheldahl LC, Zeisler J, Dube M-P et al. Mutant frizzled-4 disrupts retinal angiogenesis in familial exudative vitreoretinopathy. Nature Genet 2002; 32: 326–330.
Toomes C, Bottomley HM, Jackson RM, Towns KV, Scott S, Mackey DA et al. Mutations in LRP5 or FZD4 underlie the common familial exudative vitreoretinopathy locus on chormosome 11q. Am J Hum Genet 2004; 74: 721–730.
Kaykas A, Yang-Snyder J, Heroux M, Shah K, Bouvier M, Moon RT . Mutant frizzled 4 associated with vitreoretinopathy traps wild-type frizzled in the endoplasmic reticulum by oligomerization. Nat Cell Biol 2004; 6: 52–58.
Ishikawa T, Tamai Y, Zorn AM, Yoshida H, Seldin MF, Nishikawa S et al. Mouse Wnt receptor gene Fzd5 is essential for yolk sac and placental angiogenesis. Development 2001; 128: 25–33.
Monkley S, Delaney S, Pennisi D, Christiansen J, Wainwright B . Targeted disruption of the Wnt2 gene results in placentation defects. Development 1996; 122: 3343–3353.
Gong Y, Slee RB, Fukai N, Rawadi G, Roman-Roman S, Reginato AM et al. LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 2001; 107: 513–523.
Li Y, Muller B, Furhmann C, van Nouhuys CE, Laqua H, Humphries P et al. The autosomal dominant familial exudative vitreoretinopathy locus maps to 11q and is closely linked to D11S533. Am J Hum Genet 1992; 51: 749–754.
van Nouhuys CE . Dominant exudative vitreoretinopathy and other vascular developmental disorders of the peripheral retina. In: Bagolini B, von Bahr G, Blodi FC, Francois J, Friedmann AJ, Goldmann H et al. (eds) Documenta Ophthalmologica. W. Junk: The Hague, 1982, p 414.
Kondo H, Ohno K, Tahira T, Hayashi H, Oshima K, Hayashi K . Delineation of the critical interval for the familial exudative vitreoretinopathy by linkage and haplotype analysis. Hum Genet 2001; 108: 368–375.
Price S, Perian N, Humphries A, Woodruff G, Trembath R . Familial exudative vitreoretinopathy linked to D11S522 in a large Asian family with consanguinity. Ophthalmic Genet 1966; 17: 53–57.
Gow J, Oliver G . Familial exudative vitreoretinopathy. Arch Ophthalmol 1971; 86: 150–155.
Feldman E, Norris J, Cleasby G . Autosomal dominant exudative vitreoretinopathy. Arch Ophthalmol 1983; 101: 1532–1535.
Nicholson D, Galvis V . Criswick-Schepens syndrome (familial exudative vitreoretinopathy): study of a Columbian kindred. Arch Ophthalmol 1984; 102: 1519–1522.
Miyakubo H, Inohara N, Hashimoto K . Retinal involvement in familial exudative vitreoretinopathy. Ophthalmologica 1982; 185: 125–135.
Shastry B, Hiraoka M, Trese D, Trese M . Norrie disease and exudative vitreoretinopathy in families with affected female carriers. Eur J Ophthalmol 1999; 9: 238–242.
Sims K, Irvine A, Good W . Norrie disease in a family with a manifesting female carrier. Arch Ophthalmol 1997; 115: 517–519.
Meire F, Lafaut B, Speleman F, Hanssens M . Isolated Norrie disease in a female caused by a balanced translocation t(X,6). Ophthalmic Genet 1998; 19: 203–207.
Shastry BS, Pendergast SD, Hartzer MK, Liu X, Trese M . Identification of missense mutation in the Norrie disease gene associated with advanced retinopathy of prematurity. Arch Ophthalmol 1997; 115: 651–655.
Black G, Perveen R, Bonshek R, Cahill M, Clayton-Smith J, Lloyd IC et al . Coats' disease of the retina (unilateral retinal telangiectasis) caused by somatic mutation in the NDP gene: a role for norrin in retinal angiogenesis. Hum Mol Genet 1999; 8: 2031–2035.
Nichols BE, Bascom R, Litt M, McInnes R, Sheffield VC, Stone EM . Refining the locus for Best's vitelliform macular dystrophy and mutation analysis of the candidate gene ROM1. Am J Hum Genet 1994; 54: 95–103.
Kellner U, Fuchs S, Bornfeld N, Foerster M, Gal A . Ocular phenotypes associated with two mutations (R121W, C126X) in the Norrie disease protein. Ophthalmic Genet 1996; 17: 67–74.
Berger W . Molecular dissection of Norrie disease. Acta Anat 1998; 162: 95–100.
Hartzer M, Cheng M, Liu X, Shastry B . Localization of the Norrie disease gene by mRNA in situ hybridization. Brain Res Bull 1999; 49: 355–358.
Acknowledgements
Presented in part at the Association for Research in Vision and Ophthalmology (ARVO) in Ft. Lauderdale, Florida on April 30, 2000. Supported by an unrestricted grant from Research to Prevent Blindness (New York, NY) to the Department of Ophthalmology and Visual Sciences, The University of Iowa Carver School of Medicine, The Carver Endowment to Molecular Ophthalmology, National Institutes of Health (EMS) and the Howard Hughes Medical Institute (EMS). Proprietary interest: None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Allen, R., Russell, S., Streb, L. et al. Phenotypic heterogeneity associated with a novel mutation (Gly112Glu) in the Norrie disease protein. Eye 20, 234–241 (2006). https://doi.org/10.1038/sj.eye.6701840
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.eye.6701840
